rs137852986

Variant summary

Our verdict is Pathogenic. The variant received 20 ACMG points: 20P and 0B. PVS1PS3PP5_Very_Strong

The NM_032043.3(BRIP1):​c.2392C>T​(p.Arg798*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000287 in 1,592,634 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000699691: Publications also reported experimental evidence evaluating an impact on protein function, and demonstrated defective ATP hydrolysis and the loss of helicase activity (e.g. London_2008, Barthelemy_2016).; SCV000292128: A functional study has shown that the mutant transcript undergoes nonsense-mediated decay (PMID:26921362).; SCV000600905: The variant was associated with decreased protein expression in experimental studies (PMID:16153896 (2005)).; SCV001550349: Analysis of the variant protein, from lymphoblastoid cell lines, by immunoblotting showed an absence of the protein in both homozygous and heterozygous carriers and absence of homologous recombination (Levran 2005, Litman 2005).". Synonymous variant affecting the same amino acid position (i.e. R798R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.00016 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00030 ( 0 hom. )

Consequence

BRIP1
NM_032043.3 stop_gained

Scores

3
3

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:47O:2

Conservation

PhyloP100: 3.47

Publications

84 publications found
Variant links:
Genes affected
BRIP1 (HGNC:20473): (BRCA1 interacting helicase 1) The protein encoded by this gene is a member of the RecQ DEAH helicase family and interacts with the BRCT repeats of breast cancer, type 1 (BRCA1). The bound complex is important in the normal double-strand break repair function of breast cancer, type 1 (BRCA1). This gene may be a target of germline cancer-inducing mutations. [provided by RefSeq, Jul 2008]
BRIP1 Gene-Disease associations (from GenCC):
  • familial ovarian cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Fanconi anemia
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet
  • Fanconi anemia complementation group J
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary breast carcinoma
    Inheritance: AD Classification: STRONG, LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, ClinGen
  • colorectal adenoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 20 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PS3
PS3 evidence extracted from ClinVar submissions: SCV000699691: Publications also reported experimental evidence evaluating an impact on protein function, and demonstrated defective ATP hydrolysis and the loss of helicase activity (e.g. London_2008, Barthelemy_2016).; SCV000292128: A functional study has shown that the mutant transcript undergoes nonsense-mediated decay (PMID: 26921362).; SCV000600905: The variant was associated with decreased protein expression in experimental studies (PMID: 16153896 (2005)).; SCV001550349: Analysis of the variant protein, from lymphoblastoid cell lines, by immunoblotting showed an absence of the protein in both homozygous and heterozygous carriers and absence of homologous recombination (Levran 2005, Litman 2005).
PP5
Variant 17-61716051-G-A is Pathogenic according to our data. Variant chr17-61716051-G-A is described in ClinVar as Pathogenic. ClinVar VariationId is 4738.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032043.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRIP1
NM_032043.3
MANE Select
c.2392C>Tp.Arg798*
stop_gained
Exon 17 of 20NP_114432.2Q9BX63-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRIP1
ENST00000259008.7
TSL:1 MANE Select
c.2392C>Tp.Arg798*
stop_gained
Exon 17 of 20ENSP00000259008.2Q9BX63-1
BRIP1
ENST00000682453.1
c.2392C>Tp.Arg798*
stop_gained
Exon 18 of 21ENSP00000506943.1Q9BX63-1
BRIP1
ENST00000683039.1
c.2392C>Tp.Arg798*
stop_gained
Exon 18 of 21ENSP00000508303.1Q9BX63-1

Frequencies

GnomAD3 genomes
AF:
0.000158
AC:
24
AN:
151992
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000166
AC:
41
AN:
247008
AF XY:
0.000187
show subpopulations
Gnomad AFR exome
AF:
0.0000623
Gnomad AMR exome
AF:
0.0000885
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000295
Gnomad OTH exome
AF:
0.000333
GnomAD4 exome
AF:
0.000301
AC:
433
AN:
1440642
Hom.:
0
Cov.:
29
AF XY:
0.000309
AC XY:
221
AN XY:
716002
show subpopulations
African (AFR)
AF:
0.0000903
AC:
3
AN:
33232
American (AMR)
AF:
0.0000905
AC:
4
AN:
44202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25786
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39098
South Asian (SAS)
AF:
0.0000369
AC:
3
AN:
81324
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52550
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5702
European-Non Finnish (NFE)
AF:
0.000357
AC:
392
AN:
1099290
Other (OTH)
AF:
0.000521
AC:
31
AN:
59458
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.431
Heterozygous variant carriers
0
19
39
58
78
97
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000158
AC:
24
AN:
151992
Hom.:
0
Cov.:
31
AF XY:
0.000108
AC XY:
8
AN XY:
74220
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41386
American (AMR)
AF:
0.000262
AC:
4
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10552
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
67996
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000183
Hom.:
0
Bravo
AF:
0.000321
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000148
AC:
18

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
12
-
-
Fanconi anemia complementation group J (12)
6
-
-
Familial cancer of breast (6)
6
-
-
Hereditary cancer-predisposing syndrome (6)
6
-
-
not provided (6)
4
-
-
BRIP1-related disorder (4)
3
-
-
Familial cancer of breast;C1836860:Fanconi anemia complementation group J (3)
2
-
-
Ovarian cancer (2)
1
-
-
Breast and/or ovarian cancer (1)
1
-
-
Breast cancer, early-onset (1)
1
-
-
Breast-ovarian cancer, familial, susceptibility to, 1 (1)
1
-
-
Esophageal atresia/tracheoesophageal fistula;C0346153:Familial cancer of breast;C1836860:Fanconi anemia complementation group J (1)
1
-
-
Fanconi anemia (1)
1
-
-
Gastric cancer (1)
1
-
-
Inherited ovarian cancer (without breast cancer) (1)
1
-
-
Malignant tumor of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.41
D
BayesDel_noAF
Pathogenic
0.60
CADD
Pathogenic
40
DANN
Uncertain
1.0
Eigen
Pathogenic
0.83
Eigen_PC
Uncertain
0.62
FATHMM_MKL
Uncertain
0.88
D
PhyloP100
3.5
Vest4
0.87
GERP RS
3.5
Mutation Taster
=0/200
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.17
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137852986; hg19: chr17-59793412; COSMIC: COSV51996261; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.